Logo
C

Carbon Biosciences

34 employees

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Product Research

Date founded

2021

Funding rounds raised

Total raised

$38M

from 6 investors over 6 rounds

C

Carbon Biosciences raised $38M on June 21, 2022

Investors: Astellas Venture Capital L.L.C., Longwood Fund, Camford Capital, UTokyo Innovation Platform Co., Ltd., Solasta Ventures and Agent Capital

FAQ